Founded in 2021, tackling the biggest challenges in medicine
Our select membership of leading global life sciences, technology, healthcare and academic organizations are together developing novel causal artificial intelligence and machine learning (AI/ML) and unconventional computing strategies for understanding human biology – and then applying these to deliver better medicine and improve health for people around the world.
GAIRI is following the example of the collaborative R&D engines that revolutionized telecommunications, electronics and theoretical physics to accelerate the development and application of AI/ML solutions to medicine and healthcare.
By convening leaders from across industry and academia, we aim to eliminate the bottlenecks of traditional scientific and applied research; de-risk the development of new tools, approaches and products; and provide a direct link between innovation and medical impact.
Genuity’s AI team has a long track record of landmark advances in the application of machine learning and unconventional computing to human biology. Peer-reviewed and published, our innovative applications of five core pillars of know-how span a broad range of capabilities, diseases and challenges from drug discovery and development to digital medicine. These include:
GAIRI is bringing together industry and academic leaders not only to push the leading-edge of AI/ML strategies and tools, but to speed their use in bringing to market products to benefit patients.
Members have a seat at the table to help to choose the next big challenges to solve in AI/ML, probabilistic programming and unconventional computing, as well as real-time access to novel tools and algorithms as they are developed for use by their own teams.
To speed the application of these methodological advances, members have privileged access to the Genuity AI team to work on their in-house programs, as well as the an insider view of and ability to help to direct and partner on Genuity's target discovery and development programs in cardiovascular disease, cancer, NASH and Alzheimer's, among others.
Genuity's AI/ML team publishes its discoveries and novel methods in leading peer-reviewed journals. Below are a selection of recently published breakthrough contributions, from the first successful application of quantum approaches to human multiomics data to in vivo-validated causal biology in cardiovascular disease.